Algert Global LLC Cyma Bay Therapeutics, Inc. Transaction History

Algert Global LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $101,077 - $195,833	-8,003 Reduced 8.62%	84,883 $2.01 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $1.01 Million - $1.64 Million	92,886 New	92,886 $1.39 Million
Q1 2023 May 12, 2023	SELL	$5.88 - $9.59 $226,203 - $368,927	-38,470 Reduced 71.84%	15,080 $131,000
Q4 2022 Feb 13, 2023	SELL	$3.22 - $6.27 $16,711 - $32,541	-5,190 Reduced 8.84%	53,550 $336,000
Q3 2022 Nov 15, 2022	SELL	$2.77 - $4.25 $107,625 - $165,129	-38,854 Reduced 39.81%	58,740 $206,000

Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $85,312 - $168,144	49,600 Added 103.35%	97,594 $288,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $2,382 - $3,130	860 Added 1.82%	47,994 $149,000
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $82,203 - $117,069	25,450 Added 117.37%	47,134 $159,000
Q3 2021 Nov 15, 2021	BUY	$3.47 - $4.42 $75,243 - $95,843	21,684 New	21,684 $79,000
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $123,991 - $154,832	-31,470 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.23 - $6.55 $81,977 - $126,939	19,380 Added 160.3%	31,470 $143,000
Q4 2020 Feb 12, 2021	SELL	$5.73 - $9.03 $124,570 - $196,312	-21,740 Reduced 64.26%	12,090 $69,000
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $151,126 - $329,564	-45,520 Reduced 57.37%	33,830 $245,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $4.25 $111,883 - $337,237	79,350 New	79,350 $277,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.